Related Experiment Video
Updated: Jun 9, 2026
06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.4K
Refractory juvenile xanthogranuloma of the mastoid bone responsive to trametinib
Isaac Hauk1, Ignacio Gonzalez-Gomes2, Deepak Chellapandian1
1Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, USA.
Pediatric Blood & Cancer
|July 20, 2024
Abstract
No abstract available in PubMed .
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...